Some of these factors showed trends but did not reach statistical significance, possibly due to sample size or the distinct characteristics of de novo HF patients compared to chronic HF populations.
← all excerpts
NT-proBNP in Acute De Novo Heart Failure: A Key Biomarker for Predicting Myocardial Recovery-COMFE Registry.
2
—
—
The sentences
Regarding comorbidities, the group with persistent reduced EF had more cardiovascular risk factors, although without statistically significant differences except for chronic kidney disease (more frequent in the non-recovery group) and peripheral artery disease (trend toward significance).